Status:
COMPLETED
Pharmacokinetics of Ghrelin
Lead Sponsor:
University of Aarhus
Conditions:
Healthy Subjects
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
The main purpose of this study is to determine the half life of the hormone "ghrelin" in the human body. Other purposes are to investigate the effect of ghrelin on appetite and cardiovascular function...
Detailed Description
Ghrelin is a recently described acylated peptide hormone produced by the enteroendocrine cells of the mucosal epithelial layer in the ventricle. Ghrelin is the endogenous ligand for the growth hormone...
Eligibility Criteria
Inclusion
- Healthy
- Male
- BMI \< 25 kg/m2
- Non-smoker
- Age \< 40 yrs
Exclusion
- Any known disease
- Any medication (except OTCs)
- Former malignant disease
- Alcoholism
- Blood donation (with in 6 months)
- Allergy to test medication
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00116025
Start Date
March 1 2005
End Date
January 1 2006
Last Update
February 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8000